Participants 15 39 4
autism spectrum disorder
Participants 250 431 6
short-term treatment effects of atomoxetine on autism spectrum disorder (ASD) symptoms in children and adolescents with both ASD and attention-deficit/hyperactivity disorder (ADHD).
Participants 440 499 7
A total of 97 patients 6-17 years of age, with ASD and ADHD
